Contact us at:
Pragya Sharma hold her master degree in Pharmaceutical Chemistry at Banasthali Vidyapith, Rajasthan, India & her PhD in Computer-Aided drug design focusing on Metabolic Syndrome. Currently, she is working as an Assistant Professor in Amity University, Rajasthan, India. She is a member of Association of Pharmacy Professionals (life membership), & served as reviewer in reputed journal & in Archives of Pharmacy and Pharmacology Research as an Associate Editor.
Computer-Aided Drug Design, Medicinal Chemistry, Pharmaceutical Chemistry, Drug Discovery & Development, Molecular docking & Quantitative Structure Activity Relationship studies.
• Worked closely with project leads and co-investigators to drive teams to meet milestones and delegated deliverables. • Managed multiple complex cross-functional projects while keeping to critical-path timelines. • Cross-functional team leadership facilitating collaboration across board to achieve deliverable goals. • Prepared research manuscripts for publication, grant proposals involving multiple PIs, annual progress report submissions to NIH for each project. • Actively led internal and monthly team meetings, presented progress to NIH.
Biotechnology
My work interest is in the area of formulation development, nanomaterials engineering, and analytical development which includes synthesis of nanomaterials, development of formulations for drug delivery, and analytical methods development for small molecules, peptides, and nucleic acids. My working proficiency mainly resides in the fields of pharmaceutical science, nanotechnology, biomedical sciences, analytical chemistry, organic chemistry, and biotechnology. According to my interest and experience so far, I have developed expertise in developing fluorescent/non-fluorescent nanomaterials, nano-formulations, biological formulation, theranostics, imaging, and image-guided delivery systems.
Pharmaceutical Science, Nanotechnology, Biomedical Sciences, Analytical Chemistry, Organic Chemistry and Biotechnology
Dynamic, Versatile, and self-motivated Research Scientist with 8 years of detailed research experience in Synthetic Organic and Medicinal Chemistry. Pragmatic strategist able to define research programs in order to meet organizational priorities. Proven ability to manage challenging research schedules while working in complex and highly demanding environments. Passionate about hands-on organic synthesis with a broad knowledge of modern organic chemistry and synthetic methods, crystallization techniques, metal-catalyzed reactions, and multi-step synthesis; in-depth knowledge and hands-on experience with a wide range of techniques in synthesis, purification using flash column chromatography, Combi Flash, Gilson, Isolera, and spectroscopic characterization of novel compounds (NMR, LC-MS, HPLC etc). Proven Hands-on experience in Drug discovery, Lead optimization, and Synthesis Characterization of Anti-viral Drugs for Age-related Macular Diseases.
Molecular Modeling in Drug Discovery, Synthetic Organic and Medicinal Chemistry
I was born in Aydin, Turkey, in 1969. I was graduated from Ege University Medical School in 1993. In 1994, I started my residency in Dokuz Eylul University Medical School, Department of Emergency Medicine. I conducted research on the “Role of end-tidal CO2 monitoring in patients intubated and resuscitated in the emergency department” as my thesis for specialty graduation in 1998. I have worked as a faculty member between 1998 and 2007 in Dokuz Eylul University Medical School, Dept. of Emergency Medicine. I have gained docentship title in October 2004. In the meantime, I completed the Fellowship Program in International Emergency Medicine Pennsylvania State University, Dept. of Emergency Medicine, Hershey, PA in June-August 2005. I have served as the chairman of the department in DEU between April 2005 and September 2007. I have been in charge of the ED of Istanbul Bakirkoy Research and Training Hospital for the Turkish Ministry of Health between 2007 and 2009. I have served as a faculty member in Acıbadem University Medical School, Dept. of Emergency Medicine between 2009 and 2015. In the meantime (2011), I have also participated in the refreshment work for the Joint Commission International (JCI) certification in the Acibadem Bakirkoy Hospital. At the end of 2015 I started serving in the Dept. of Emergency Medicine, Istanbul Education and Research Hospital, Fatih, Istanbul.
Resuscitation, toxicology/poisoning, pain management, trauma, advanced life support, emergency medicine, injury prevention, procedures, surgical emergencies, disaster medicine, education in medicine, prehospital medicine.
Amgad Mohammed Rabie Hamed Fouda has completed his MSc and Postgraduate studies in Pharmaceutical and Biomedical Sciences at the age of 30 years from the Faculty of Pharmacy, Mansoura University, Egypt. He is one of the most famous and reputed Egyptian and Arab pharmacists, researchers and scientists. His new researches focused on the synthesis, discovery, and development of new drugs and medicines for the most resistant and untreated human diseases. He is the head of pharmacists at the Dikernis General Hospital (Mansoura, Egypt), a premier governmental hospital in Egypt. He has published more than 25 papers in very reputed journals and serving as an Editorial Board Member of great repute.
Department of Pharmaceutical Organic Chemistry and Medicinal Chemistry, Head of Drug Discovery
in-vivo and in-vitro Pharmacological Studies ,Molecular Pharmacology,Recombinant DNA Techniques ,Electrophysiology ,Phytotherapy
Jeffrey M. Witkin is currently CEO of Witkin Consulting Group in Carmel, IN USA. His work focuses on facilitating drug discovery and development in the areas of psychiatry, epilepsy, and pain. He is the co-inventor of CERC-611, currently in clinical development for epilepsy. This molecule is the first AMPA receptor antagonist selective for the auxiliary protein TARP gamma-8. He also was the biology leader for the discovery of BTRX-246040, the first NOP receptor antagonist in clinical trials for depression. Dr. Witkin headed an antidepressant discovery lab at Eli Lilly and Company, Indianapolis, IN USA for 17 years and headed the Drug Development Group at the National Institutes on Drug Abuse for 14 years. He is the author of over 200 research papers and is on the editorial board of number of pharmacology journals. His expertise is in animal models of psychiatric disorders, behavioral pharmacology, in the discovery on novel antiepileptics, drugs for the therapeutic treatment of anxiety and Depression.
Pharmacy and phormacology
He graduated in Chemical Physics at Chemist Faculty UNAM in 1999. Since that time he is working in the Nuclear Science Institute UNAM. His field of expertise is radiation chemistry, fluorinated polymers, drug delivery, and synthesis of smart polymers. Recently his research team is working on the sensitivity copolymers for drug delivery. Awards Medal Gustavo Baz Prada for Bs in 1993 UNAM, Medal Alfonso Caso for Ph D in 1999, and LAS/ANS award for best publication of the year in 2010 by Nuclear American Society Latinoamerican Section. International articles 117, chapters in book 20, thesis direction 41
Radiation chemistry, Fluorinated polymers, Synthesis of smart polymers and Sensitivity copolymers for drug delivery.
Respiratory Physiology, Respiratory Pathophysiology, Pharmacology, Therapeutics, Epidemiology, Pharmacotherapy of Asthma & COPD, Respiratory and Environmental Health and Health Research
Pain, Analgesia, Arthritis, Cholinergic System and Cardiovascular Neuroscience
Dr. Valerio Mammoli holds his master degree in Pharmaceutical Technology and Chemistry in 2010 at Universitiy of Camerino (IT) discussing a thesis entitled Reduced conformational freedom in subtype-selective α2-adrenoreceptor antagonists under the supervision of Professor Maria Pigini. In 2011 he began the PhD work in Pharmaceutical Science and in 2012 worked for 6 months in NIDA (NIH, Baltimore, MD) under the super vision of Dr. Amy Newman. In 2014 he defended his PhD with a thesis titled Novel imidazoline ligands potentially useful in managing pain, opiate withdrawal syndrome, and psychiatric comorbidity. In the same year, Dr. Mammoli began to work in Aptuit as medicinal chemist. In 2015 he moved to Discovery DMPK in Aptuit where he is working.
Medicinal chemistry, CNS, Receptor chemistry, Drug discovery, DMPK, PK , PKPD correlations, Automation, Discovery formulation, LC/MS-MS, ADME, Bioanalysis
Dr. Mauro Luisetto, obtained his Pharm D in 1995 from the Turin University and worked as European specialist in laboratory medicine. Currently, he works as Public Hospital Pharmacist Manager and is responsible of hospital medicinal gas quality control PC HOSP. He is also the Director of hospital medicinal gases contract implementation. His working filed and rotation is biochemistry, toxicology, blood bank, haematology. microbiology; hospital pharmacy (drugs logistic, galenic, medicinal gas quality controller , radio drugs, rx contrast agents, departmental pharmacist); clinical pathology, antidothes responsible stokes provincial PC, logistic of diagnostic in vitro), responsible for emergency drug hospital stokes.
Pathology, clinical biochemistry , toxicology, microbiology, imaging, clinical pharmacy , ph care , medicinal chemistry clinical pharmacology, pharmacoeconomy, new professional social media, biomedical database, EBM and risk management.
Pharmacology, Clinical Pharmacy and Pneumoconiosis Disease
Department of Forensic medicine and toxicology
Drug addiction and Nursing
Pharmacology, Toxicology and Pharmacy
Professor Dr. Khalid Aftab, Ph.D. has been actively engaged in teaching Pharmacology to Medical, Dental & Pharmacy graduates and research on Pharmacological studies of natural products for their Cardio-Vascular action since 1988. This work on Natural Products (novel hypotensive agents) resulted in valuable contribution and work has over 40 publications in Journals of International repute with impact factor 111. Published more than 30 research papers in Journals of International repute and few more are in process of publication. Presented more than 12 Scientific Contributions/Lectures throughout the world.
Phyto-Pharmacology/Phytomedicine, Pharmacodynamics (C.V. Studies) & Pharmacokinetics (Bio-equivalence Studies), cGMP of Pharmaceuticals, ISO 9000, 14000 & 17025, FDA, Health Canada and ICH guide line
Loutfy H. Madkour was Professor of physical chemistry and electro analytical chemistry at Chemistry Department, Faculty of Science, Al Baha University, Saudi Arabia. Scopus Author Identifier: Scopus Author ID: 57190212951; 57191194828; 57191842842 and ORCID ID Orcid.org/0000-0002-3101-8356. Received his B.Sc., M.Sc. and Ph.D. from the Cairo, Minia and Tanta Universities of the AR Egypt, respectively. He worked as a lecturer chemistry at the Tanta University since 1982 and as a professor of physical chemistry in 1999. His research fields are physical chemistry, electrochemistry, corrosion science, density functional theory, molecular dynamic simulation, quantum, theoretical chemistry, chemical equalization principles, nanoscience, nanotechnology, nanomedicine; electrometallurgy, electroanalytical chemistry, analytical chemistry, polarography, electrolytic extraction of heavy metals from natural ores and deposits, electrochemical thermodynamics and environmental chemistry. Prof. Madkour has authored/co-authored over 150 research articles in international peer-reviewed journals, including four books and ten critical reviews in the area of physical chemistry, practical and applied chemistry, corrosion science and nanoscience. He is serving in different positions in Egypt, Kuwait, Yemen, and Saudi Arabia. Prof. Madkour is appointed as the prestigious editorial board member of several international journals such as: International Journal of Industrial Chemistry (IJIC) Published by the SPRINGER; International Journal of Ground Sediment & Water; E-Cronicon Chemistry (EC Chemistry); BAOJ Chemistry; Global Drugs and Therapeutics (GDT); Chronicles of Pharmaceutical Science (ISSN 2572-7761) journal; Journal of Targeted Drug Delivery. UNIQUE PUB INTERNATIONAL UPI Journal of Pharmaceutical, Medical and Health Sciences; and Global Journal of Nanomedicine (GJN) ISSN: 2573-2374. Research and Reviews in Computational Chemistry Journal Link: http://rrcchemistry.com/index. php/rrcc/announcement/view/1 and Journal of Pharmaceutical sciences-current research (JPSCR) in the area of Pharmaceutical, Pharmacology, and Journal of Pharmacology & Pharmaceutical Research (JPPR). He is a reviewer for many international at ELSEVIER and SPRINGER journals. He is a member for many interested international societies, including American Association for the Advancement of Science (AAAS), European Desalination Society (EDS), Egyptian Chemical Society (ECS), Egyptian Corrosion Bulletin Society and American Chemical Society (ACS). He is the only corresponding author in this paper.
are physical chemistry, electrochemistry, corrosion science, density functional theory, molecular dynamic simulation, quantum, theoretical chemistry, chemical equalization principles, nanoscience, nanotechnology, nanomedicine; electrometallurgy, electroanalytical chemistry, analytical chemistry, polarography, electrolytic extraction of heavy metals from natural ores and deposits, electrochemical thermodynamics and environmental chemistry
Zeliha Selamoglu is a Professor in Medical Biology department of Nigde omer Halisdemir University, Turkey. She earned her PhD in Biology from Inonu University, She has published over 80 peerreviewed journal articles with over 700 citations and many technical reports. She is a member of Society for Experimental Biology and Medicine: Associate Membership and European association for cancer research. She has served as Editorial Board member for many Journals
Molecular Biology, Biochemistry, Biotechnology, Oxidative stress, Antioxidants, Cancer.
Dr. Ahed Alkhatib has finished his PhD from Cambell State University in 2011. I am currently working as a clinical researcher at faculty of medicine, Jordan University of Science and technology. Over the time, I have published more than 200 articles in various medical fields including neurosciences, pharmacology, and diabetes. My approaches in research include the involvement of philosophy of science in research which gives looking, and thinking in depth. I have developed several hypotheses in medicine such as the role of white matter in initiating diseases such as diabetes. In microbiology, I have demonstrated that prokaryotic cells and eukaryotic cells are similar in producing cell cycle proteins which can participate in autoimmunity diseases. For the time being, I am more interested in setting more medical hypotheses, and writing book in different fields, of which two books have already been written and distributed in the world market.
Medical Hypotheses
Ibrahim Alabbadi is a qualified pharmacist by profession since graduation in1987 King Saud University experienced in pharmaceutical marketing with multinational as well as Jordanian companies in the Middle East. He got his MBA-Marketing pharmaceutical pricing in 2001 from the University of Jordan, completed his PhD in PharmacoEconomics from Queens University UK in 2006. He is a Professor in PharmacoEconomics and pharmaceutical marketing has more than 38 publications in peer reviewed journals, supervised 13 postgraduate students in applied research, worked in the University of Jordan as an Assistant Dean for training Affairs, Director of Scientific Research Documentation Office and Local Community Development & Networking Centre Director, and Deputy General Director for Administrative Affairs Jordan University Hospital, Dean Faculty of Pharmacy industrial and pharmaceutical business tracks and head of Pharmacy Practice department, Yarmouk University Jordan.
Drug selection for formulary inclusion, Pharmaco Economic evaluations (cost-effectiveness), pharmaceutical marketing and promotion, social pharmacy, pharmaceutical pricing, health and pharmaceutical policy, health technology assessment, clinical pharmacy-Diabetes, pharmaceutical intellectual properties, scientific research documentation and marketing, universities ranking, teaching quality and accreditation, pharmacy education and curricula development, feasibility in healthcare
Dr. Maria Bernadete Riemma Pierre holds a degree in Industrial Pharmacy from the Faculty of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo - USP (1991), a Masters degree in Pharmaceuticals and Medicines from the University of Sao Paulo (1999) and a PhD in Pharmaceuticals and Medicines from the University of Sao Paulo (2004) ). He is currently an adjunct professor at the Federal University of Rio de Janeiro. He has experience in the field of Pharmacy, with emphasis on PHARMACEUTICAL / PHARMACOTECHNIC TECHNOLOGY,
skin cancer, 5-aminolevulinic acid, photodynamic therapy, mucoadhesive release systems, in vitro permeation studies, cutaneous penetration promoters, and topical / transdermal delivery systems and Pharmaceutical Nanotechnology
George Kordas studied physics at the University of Erlangen, Germany, specializing in nuclear physics. At the same university, he worked on the PhD thesis at the Department of Materials Science and Technology, specializing in glass and ceramics technology. After his studies, he was appointed at Vanderbilt University in the USA. He then moved to the Urbana-Champaign University of Illinois at the department of Materials Science and Engineering in the United States establishing together with his peers two Science and Technology Centers. In 1990, he was appointed Research Director at NCSR Demokritos. He was for seven years Professor at the University of Patras. In 2015, he founded the company Nano4chem for the implementation of technologies related to drug delivery systems. He was awarded two European Research Council grands entitled Nano-containers for drug transport for targeted treatment of prostate and breast cancer which achieves highly localized cancer chemotherapy. He supervised more than 50 students to complete their PhD degree most of them becoming professors in Greece and around the world. He published more that 240 papers in refereed journals, receiving five patents and gave more than 100 invited talks several them as a keynote speaker. He was visiting professor at the Universities Sao Paolo, Sao Carlos, Korean Institute of Technology, University of Kyoto, MPIP Germany, Technical University of Nurnberg Germany, Weizmann Institute of Sciences. He received several awards and honors around the world.
The current work is centered on drug delivery systems for targeted chemotherapy
Sermin Tetik is received her PhD degree in Biochemistry at University of Marmara (Istanbul-Turkey). Currently, she is profesor at the same University in Istanbul-Turkey. She has joined two research as fellowships that one of them is at the Center of Pharmacology-Pathology of Medicine School of Loyola University, Chicago in the 2013 and Florida Cancer Research at Florida University, Orlando, USA in the 2016. Dr. Tetik is currently the project director with her research team focusing on thrombosis hemostasis, proteomics and modification of protein structure and function, and cancer study. She has successfully completed her administrative responsibilities as an advisor of several PhD and MSc students. She has published more than 40 scientific journals and over to 40 international abstract in reputed journals, has several book chapters, and gave many invited lecture. She has been served as editorial board member of repute journals, she has received several awards and honors.
Pharmaceutical sciences, Thrombosis and hemostasis, Clinical research, Proteomics, Pathophysiology of Several Diseases, Biomarkers on Cardovascular Diseases, Analytical and Instrumental Approach for Biomarker Discovery and Mass spectrometry
Vural has won a Science Award by being among the top 100 researchers and scientists. The IBC top 100 Scientists and Educators 2011, Cambridge-England. Dr. Vural has participated in international courses related to her field in 1997, 2000 and 2002 respectively. DNA Technologies, Swansea, England, Gene Manuplation and Genomics, Western Michigan State, USA and Cancer Research, Hawaii Cancer Research Center. Dr. Vural has a number of national/international publications and research as well as lessons for undergraduate and graduate students. She has written international book and book chapters. She is editor and referee in the international journals. The university has received official duties for industrial cooperation, domestic and international consulting, expertise and representation at UNESCO meetings. She has also worked on many scientific projects.
Molecular modeling studies on cancer molecular biology and epigenetic mechanisms, genomic and metabolic pathways. Plant, animal, human, microorganism, tissue, blood, hair, forensic medicine as well as organic substances isolated from archaeological remains, archaeometry, biological anthropology. Gene manipulation, identification of gene expressions related to diseases, mutation detection, cell culture studies, apopitosis and cancer developmet, siRNA, miRNA, and the many metabolic and necrotic pathway studies and on living and ancient DNA assays and OMIC technologies.
Experimenatal Study, Statistical Analysis, Colorectal Surgery
Chan Kam Tim Michael is a practicing private Dermatologist in Hong Kong. He received his Fellowship from Hong Kong Academy of Medicine (FHKAM) as a registered Dermatologist since 1998. He received his post- doctoral training in University of California, Los Angeles (UCLA) in 1997. He is now the Vice President of the Association of Integrative Aesthetic Medicine (AIAM) in Hong Kong. In 2017, he was invited and served as editorial board member of the following International Journals Journal of Anatomy and Physiological Studies, the Cognitive Neuroscience Journal, Research Journal of Nervous System, Medical Reports and Case Studies, Advances in Neurology and Neuroscience. He has been the Editor of Hong Kong Journal of Dermatology and Venereology from 2002 to 2007. Honorary Clinical Assistant Professor of the Faculty of Medicine in The University of Hong Kong From July 2007 to June 2009. He also fulfilled his part time lectureship in the Baptist University of Hong Kong in teaching a Master Course on Public Health and Common Goods for the Public since 2013. Currently, he is the Adjunct Professor of the Master Course of Common Goods and Public Health in the Baptist University of Hong Kong since 2018.
Epidermal skin barrier, Nervous system, Sensitive skin syndrome, Transient Receptor Potential (TRP) Pathways, Acneiform facial skin eruption and Rosacea, Pathogenetic Mechanisms, Psychodermatology and Neurodermatology
Mosaad Sayed Mohamed Abd-Alla is currently an Emeritus Professor of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Helwan University. Born 17/2/1951, Cairo, Egypt. He graduated from Faculty of Pharmacy, Cairo University in 1974 (very good with honour) and appointed as instructor of organic chemistry in the department of organic chemistry, Faculty of Pharmacy, Cairo University. He had M. Pharm. Sci. (organic chemistry), 1980 and phD pharm. Sci. (organic chemistry),1983, faculty of Pharmacy, Cairo University. He worked assistant lecturer (1980-1983) and lecturer of organic chemistry (1983-1988) in the department of organic chemistry faculty of Pharmacy, Cairo University. In 1984-1985 he had a post-doctoral research fellowship in the department of medicinal chemistry, Faculty of Pharmacy, Minnesota University, Minnesota, USA. In 1988, he travelled to Japan to attend a training program (Jeolcompany) on MNR Spectroscopy. He had promoted to Assistant Professor in the department of organic chemistry faculty of Pharmacy, Cairo University. In 1996 he had become a full Professor in the same department. In 1996, he moved to theFaculty of Pharmacy, HelwanUniversity to be the head of the department of pharmaceutical organic chemistry and Vice-Dean for Graduate Studies and Researches. In 2005-2011 he appointed Dean of Faculty of Pharmacy, HelwanUniversity. He worked since 1976 to the date in teaching and conducting researches in the field of organic, pharmaceutical, and medicinal chemistry which is the field of his interest. His contribution in the chemistry researches involves more than 75 publications in international journals in the field of organic pharmaceutical and medicinal chemistry in addition to more than 30 master and phD thesis. As a peer reviewer he refereed more than 500 organic and medicinal chemistry articles
organic pharmaceutical and medicinal chemistry
Dr. Loai Aljerf is a Prof in the Department of Basic Sciences, Faculty of Dental Medicine/Damascus University. He is a specialist in analytical and industrial chemistry. He obtained many awards and published more than 30 peer-reviewed papers (two of them in French) in Environmental Sciences, Green Chemistry, Analytical Chemistry, Synthesis Chemistry, Concrete, Ceramics, Paper Industry, Petrochemical, Extraction, Separation, Lithium-Ion-Batteries, and Oral Chemistry. He is a partner in Advances in Cleaner Production Network, and a member of the German Chemical Society e.V. (GDCh) and the American University of Beirut. He is a member of the higher committee of the 6th International Workshop-Advance in Cleaner Production (Sao Paulo, Brazil (May 24th to 26th - 2017)). Loai Aljerf is in the Cambridge Scholars Publishing-Life Science Advisory Board and an editor of more than 20 journals and a reviewer for Top journals in Industry, Chemical Engineering, and Environmental Chemistry
Industrial Chemistry, Analytical Chemistry, Environmental Chemical Engineering, Environmental Science, Environmental Chemistry, Green Chemistry, Cement Industry, Ceramics, Paper Industry, Advances in Cleaner Production, Climate Change, Pollution, Wastewater Treatment, Air Pollution, Eco-friendly Biopolymers, Persistent Organic Pollutants, Polychlorinated biphenyls, Polycyclic Aromatic Hydrocarbons, Nanotechnology, Adsorption, Ecology and Natural Resources, Biodiversity, Sustainable Development, Waste Management, Environmental Management, Life Cycle Assessment, Ecodesign, Design for the Environment, Energy Labeling, Eco-efficiency, Chromatography, HPLC, GC, MS, AAS, Spectroscopy, and Lithium-Ion-Batteries
Chemical Sciences
Prof. Sinerik Ayrapetyan has completed his PhD in Cell Biophysics in the Institute of Physiology of Ukraine Academy of Sciences, Kiev. He is the head of Research Council and the coordinator of UNESCO Chair in Life Sciences at Life Sciences International Postgraduate Educational Center, Yerevan, Armenia. His current research interest is Intracellular Signaling System in Norm and Pathology. He has published 7 international books and 115 papers. He is an Editor in Chief of the journal Bioavailability and Bioequivalence, and a member of editorial board of the journals: Electromagnetic Biology and Medicine, Journal of International Dental and Medical Research, ISRN Biophysics, Advances in Life Sciences, Applied Pharmacy, European Journal of Biophysics, Biochimica et Biophysica Acta etc. He is a member of International Coordination Council of WHO and number of professional international societies.
Metabolic regulation of excitable cell membrane function, Neurochemistry, Biophysics
Fathi Sherif is a professor of pharmacology and was acting as a dean and vice-dean of faculty of Pharmacy, University of Tripoli, Libya. He received his PhD in medicinal pharmacology from faculty of Medicine, University of Uppsala, Sweden (1992) and postdoctoral training in neuroscience in Uppsala University. He won WHO award for the youngest medical researcher in 1995 from world health organization. He is a lecturer of pharmacology at department of pharmacology and clinical pharmacy since 1993 and held a position of head of the department and head of postgraduate office at the university. Head of research unit at National Medical Research Center of ethno-pharmacology (traditionally used of medicinal plants and their potential actions on the CNS using behavioral models in rats). A long-term involve in neuropsychopharmacology (GABA & MAO systems) in patients as well as long interest in animal behavioral pharmacology. He published several articles about the role of inhibitory transmitters in neuropsychiatric disorders. He is supervising several postgraduate students in the area of clinical and basic pharmacology leading to M.Ph. He is editor in chief of Libyan J Med Res (ISSN 2312-5365) and Pharm Pharm Int J (ISSN 2373-6367, USA) and editor of several international journals.
Neuro-Psychopharmacology: Mainly studying the role of brain and peripheral inhibitory amino acids (e.g. GABA and MOA) in certain neurological and psychiatric disorders in experimental animals and man; Ethno-Pharmacology: Screening of certain medicinal plants that have been used traditionally in Libya for selective biological action without side effects and toxicity; Pharmaco-Epidemiology: Studying the patterns of drug use in the society, addressing the pharmaco-epidemiological, clinical, pharmaco-economic, standards and implementation aspects of such services
a Creative Commons Attribution 4.0 International License. Based on a work at www.irispublishers.com.
Best viewed in
| Above IE 9.0 version | Privacy Policy
